Regen BioPharma Inc SEC filings RGBPP

Regen BioPharma Inc has 263 filings in SEC EDGAR's recent list, going back to Oct 15, 2013. Its latest annual report, Form 10-K, was filed on Dec 30, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement). The company's fiscal year ends on September 30.

Form Description Filed Period
10-Q Quarterly report Aug 17, 2026 Jun 30, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
10-Q Quarterly report Feb 13, 2026 Dec 31, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
10-Q Quarterly report May 28, 2025 Mar 31, 2025
10-Q Quarterly report May 16, 2025 Dec 31, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
10-Q Quarterly report Apr 24, 2024 Mar 31, 2024
10-Q Quarterly report Jan 19, 2024 Dec 31, 2023
10-Q Quarterly report Jul 25, 2023 Jun 30, 2023
10-Q Quarterly report Apr 18, 2023 Mar 31, 2023
10-Q Quarterly report Jan 19, 2023 Dec 31, 2022
10-Q Quarterly report Jul 22, 2022 Jun 30, 2022
10-Q Quarterly report Apr 21, 2022 Mar 31, 2022
10-Q Quarterly report Jan 20, 2022 Dec 31, 2021
10-Q/A Amended quarterly report Dec 22, 2021 Jun 30, 2021
10-Q Quarterly report Aug 27, 2021 Jun 30, 2021
10-Q Quarterly report Aug 18, 2021 Mar 31, 2021
10-Q Quarterly report Aug 13, 2021 Dec 31, 2020
10-Q Quarterly report Aug 5, 2021 Jun 30, 2020
10-Q Quarterly report Aug 5, 2021 Mar 31, 2020
10-Q Quarterly report Aug 5, 2021 Dec 31, 2019
10-Q Quarterly report Oct 24, 2019 Jun 30, 2019
10-Q Quarterly report Aug 29, 2019 Mar 31, 2019
10-Q Quarterly report Feb 12, 2019 Dec 31, 2018
10-Q Quarterly report Aug 6, 2018 Jun 30, 2018
10-Q Quarterly report May 14, 2018 Mar 31, 2018
10-Q Quarterly report Feb 6, 2018 Dec 31, 2017
10-Q Quarterly report Aug 7, 2017 Jun 30, 2017
10-Q Quarterly report May 5, 2017 Mar 31, 2017
10-Q/A Amended quarterly report Apr 28, 2017 Dec 31, 2016
10-Q/A Amended quarterly report Apr 28, 2017 Jun 30, 2016
10-Q/A Amended quarterly report Apr 28, 2017 Mar 31, 2016
10-Q/A Amended quarterly report Apr 28, 2017 Dec 31, 2015
10-Q/A Amended quarterly report Apr 28, 2017 Jun 30, 2015
10-Q/A Amended quarterly report Apr 28, 2017 Mar 31, 2015
10-Q/A Amended quarterly report Mar 30, 2017 Dec 31, 2016
10-Q/A Amended quarterly report Mar 30, 2017 Jun 30, 2016
10-Q/A Amended quarterly report Mar 30, 2017 Mar 31, 2016
10-Q/A Amended quarterly report Mar 30, 2017 Dec 31, 2015
10-Q/A Amended quarterly report Mar 30, 2017 Jun 30, 2015
10-Q/A Amended quarterly report Mar 30, 2017 Mar 31, 2015
10-Q Quarterly report Jan 27, 2017 Dec 31, 2016
10-Q Quarterly report Aug 1, 2016 Jun 30, 2016
10-Q Quarterly report Apr 29, 2016 Mar 31, 2016
10-Q Quarterly report Jan 28, 2016 Dec 31, 2015
10-Q Quarterly report Jul 29, 2015 Jun 30, 2015
10-Q Quarterly report May 7, 2015 Mar 31, 2015
10-Q Quarterly report Feb 4, 2015 Dec 31, 2014
10-Q Quarterly report Aug 7, 2014 Jun 30, 2014
10-Q Quarterly report May 5, 2014 Mar 31, 2014

Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RGBP (OTC), RGBPP (OTC)
Fiscal year ends
September 30
Incorporated in
NV
Headquarters
La Mesa, CA
SEC filer status
, Emerging growth company
SEC CIK
1589150

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.